DUBLIN--(BUSINESS WIRE)--The "Innovations in Wellness, Biotech, and Digital Health Platforms" report has been added to ResearchAndMarkets.com's offering.
This edition of the Life Science, Health & Wellness TechVision Opportunity Engine (TOE) analyzes recent advances in 3D food printing for health & wellness, and latest developments across drug discovery, development, and delivery platforms. The TOE also provides insights across innovative precision therapy technologies and digital health platforms.
The Life Science, Health & Wellness TOE will feature disruptive technology advances in the global life sciences industry. The technologies and innovations profiled will encompass developments across genetic engineering, drug discovery, and development, biomarkers, tissue engineering, synthetic biology, microbiome, disease management, as well as health and wellness among several other platforms.
The Health & Wellness cluster tracks developments in a myriad of areas including genetic engineering, regenerative medicine, drug discovery and development, nanomedicine, nutrition, cosmetic procedures, pain and disease management and therapies, drug delivery, personalized medicine, and smart healthcare.
Companies Featured
- Natural Machines
- Upside Health
- Eko Devices Inc.
- Pfizer
- Actym Therapeutics
- Ansa Biotechnologies
- Indee Labs
- GenEdit
- Abionyx
- SNIPR BIOME ApS
- Prevencio Inc.
- visotec GmbH
- Adroit Surgical LLC
- BioXcel Therapeutics
- BenevolentAI
- Halozyme Therapeutics Inc.
- Calliditas Therapeutics AB
- Athera Biotechnologies AB
- UCB Pharma
- Abalos Therapeutics
- Gilead Sciences
- University of California, Santa Cruz
- Novartis
- Bolt Biotherapeutics
- ExCellThera
- Durect
For more information about this report visit https://www.researchandmarkets.com/r/acrspx
